
In this episode, we explore the growing threat of xylazine — a veterinary sedative increasingly found in illicit drug supplies — and what clinicians need to know when naloxone simply isn't enough. Dr. David Gorelick breaks down the current evidence on diagnosis, treatment, and the critical gaps that remain. Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 82 Xylazine ("Tranq Dope") Overdose: What Clinicians Should Know
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Difficult-to-Treat Depression: First, Second, and Third-Line Strategies

Is High-Dose Olanzapine A Clozapine Alternative?

CANMAT Guidelines: Herbs, Supplements, and Depression

Choosing the First Step in Depression Treatment: A CANMAT Guide
Free AI-powered recaps of Psychopharmacology and Psychiatry Updates and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.